Parallel and overlapping Human Immunodeficiency Virus, Hepatitis B and C virus Infections among pregnant women in the Federal Capital Territory, Abuja, Nigeria

Bassey, EB and Moses, AE and Udo, SM and Umo, AN (2009) Parallel and overlapping Human Immunodeficiency Virus, Hepatitis B and C virus Infections among pregnant women in the Federal Capital Territory, Abuja, Nigeria. [Journal (On-line/Unpaginated)]

Full text available as:

PDF - Published Version
Available under License Creative Commons Attribution No Derivatives.



Background: Risk factors that are associated with HIV infection are also associated with HBV and HCV infections in sub-Saharan Africa. The HIV-infected pregnant cohort represents a unique population and infection with the hepatitis virus is considered a public health problem worldwide. Objective: The purpose of this study was to evaluate the prevalence of Human Immunodeficiency Virus, Hepatitis B and C virus parallel and overlapping infections among pregnant women attending antenatal clinics in Federal Capital Territory (FCT), Abuja. Method: Five hundred (500) blood samples were collected from three district hospitals in the FCT and tested at Wuse General Hospital, Abuja for the presence of antibodies to HIV and Hepatitis C virus, and HBsAg by ELISA technique in accordance with the manufacturer’s instructions. HIV seropositive sera were confirmed by Western blot. Result: Of the 500 pregnant women, those detected with HIV antibodies, HBsAg and anti-HCV antibodies were 42 (8.4%), 19 (3.8%) and 8 (1.6%) respectively. The overall seroprevalence of HIV and HBV or HCV co-infection was 9.5% while 7.1% and 2.4% HIV positive pregnant women were specifically co-infected with HBV and HCV respectively. Those within the age bracket of 15-20 years had the highest prevalence of HIV (13.4%), HBV (5.1%) and HCV (1.9%) infections. Among the occupation characteristics of the women, those of them involved in trading recorded the highest prevalence of HIV (60.6%), HBV (30.3) and HCV (6.1%). HIV was higher among the married women than the singles ((8.6% vs 6.5%); with HBV infection the reverse was the case (3.0% vs 9.8%) while HCV was same for both groups. History of blood transfusion did not reflect a higher rate of HIV and HBV (1.4% vs 9.6%; 2.8% vs 4.0% respectively) unlike HCV infection with 0.5% recorded only among those that had transfusion experience. Conclusion: When monitoring the risk of hepatotoxicity to antiretroviral drugs among these group of patients caution should be maintained. Moreover, evidence of parallel and overlapping HIV, HBsAg and HCV infections among this cohort should motivate inclusion of HBV and HCV among the diseases of surveillance in the national sentinel survey in order to ascertain the bigger picture of these infections in Nigeria.

Item Type:Journal (On-line/Unpaginated)
Keywords:Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, Abuja, Nigeria
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:6560
Deposited By: Kakkilaya Bevinje, Dr. Srinivas
Deposited On:02 Jul 2009 01:46
Last Modified:11 Mar 2011 08:57

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1.Mboto CI, Davies A, Fielder M, Jewell AP. Human Immunodeficiency virus and hepatitis C co-infection in sub-Saharan West Africa. British Journal of Biomedical Sci 2006:63 1):29-37.

2.Emokpae MA, Nwokedi EE, Jegede EE. Impact of Hepatitis C Co-Infection on CD4 Cell Count in HIV Infected Subjects. Online J Health Allied Scs. 2008;7(2):3

3.Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM. The role of triple infection with hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV) type 1 on CD4+ lymphocytes levels in highly infected population of North Central, Nigeria. Mem. Inst. Oswaldo Cruz 2007;102(4):535-537.

4.Alvarez-Muñoz MT, Vázquez-Rosales JG, Torres-López FJ et al. Infection of pregnant women with hepatitis B and C viruses and risks for vertical transmission. Autumn 1997;28(3):415-9

5.Santiago-Munoz Patricia, Roberts Scott, Sheffield Jeanne, Mcelwee Barbara, Wendel George D. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J. Obstet Gynecol 2008;193(3):1270-1273

6.Pirillo Maria F; Bassani Luciana; Germinario Elena A P et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. Journal of medical virology 2007;79(12):1797-801

7.FMOH. Technical Report Nigeria National HIV/Syphilis Sero-Prevalence Sentinel Survey. 2005

8.Ezegbudo CN, Agbonlahor DE, Nwobu GO, Igwe US, Agab MI, Okpala HO. The Seroprevalence of hepatitis B surface antigen and human immunodeficiency virus among pregnant women in Anambra State, Nigeria. Shiraz e-Medical Journal April 2004;5(2):215-219

9.Rouet, François, Marie-Laure Chaix, André Inwoley et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 Study Journal of Medical Virology 2004;74:34-40.

10.Simpore, Jacques, Aly Savadogo, Denise Ilboudo et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and negative pregnant women in Burkina Faso J. Med. Virol. 2006;78:730-733,

11.Moges Feleke, Yenew Kebede, Afework Kassu et al. Seroprevalence of HIV, Hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia Ethiop.J.Health Dev. 2006'20(3):160-165


Repository Staff Only: item control page